Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kobold

Showing results (11-20 of 177) with videos related to

Pageof 18
Sort By:
Signal Transduction and Targeted Therapy|July 16, 2022
ESCRT machinery: role of membrane repair mechanisms in escaping cell deathLisa Gregor, Sophia Stock, Sebastian Kobold
Cancers|February 3, 2021
Therapeutic Strategies for Targeting IL-1 in CancerAdrian Gottschlich, Stefan Endres, Sebastian Kobold
Hematology/Oncology Clinics of North America|March 6, 2019
Innate Immune Stimulation in Cancer TherapyPeter Düwell, Simon Heidegger, Sebastian Kobold
Translational Lung Cancer Research|May 22, 2018
Can we use interleukin-1β blockade for lung cancer treatment?Adrian Gottschlich, Stefan Endres, Sebastian Kobold
Cancer Management and Research|December 29, 2010
Evolving role of cetuximab in the treatment of colorectal cancerGunter Schuch, Sebastian Kobold, Carsten Bokemeyer
Immunotherapy|February 8, 2019
Enhancing tumor T cell infiltration to enable cancer immunotherapyJin Zhang, Stefan Endres, Sebastian Kobold
Human Vaccines & Immunotherapeutics|April 5, 2018
Targeting interleukin-22 for cancer therapyAnamarija Markota, Stefan Endres, Sebastian Kobold
Molecular Therapy. Oncology|May 6, 2026
How CAR T cells can be shielded from prostaglandin E2 signaling to enhance their therapeutic activityJanina Dörr, David Andreu-Sanz, Sebastian Kobold
Mabs|March 21, 2019
Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cellsDiana Darowski, Sebastian Kobold, Christian Jost, et al.
Memo|November 15, 2021
CAR T cell therapy in solid tumors: a short reviewÖykü Umut, Adrian Gottschlich, Stefan Endres, et al.
Pageof 18

Showing results (11-20 of 177) with videos related to

Sort By:
Pageof 18
Signal Transduction and Targeted Therapy|July 16, 2022
ESCRT machinery: role of membrane repair mechanisms in escaping cell deathLisa Gregor, Sophia Stock, Sebastian Kobold
Cancers|February 3, 2021
Therapeutic Strategies for Targeting IL-1 in CancerAdrian Gottschlich, Stefan Endres, Sebastian Kobold
Hematology/Oncology Clinics of North America|March 6, 2019
Innate Immune Stimulation in Cancer TherapyPeter Düwell, Simon Heidegger, Sebastian Kobold
Translational Lung Cancer Research|May 22, 2018
Can we use interleukin-1β blockade for lung cancer treatment?Adrian Gottschlich, Stefan Endres, Sebastian Kobold
Cancer Management and Research|December 29, 2010
Evolving role of cetuximab in the treatment of colorectal cancerGunter Schuch, Sebastian Kobold, Carsten Bokemeyer
Immunotherapy|February 8, 2019
Enhancing tumor T cell infiltration to enable cancer immunotherapyJin Zhang, Stefan Endres, Sebastian Kobold
Human Vaccines & Immunotherapeutics|April 5, 2018
Targeting interleukin-22 for cancer therapyAnamarija Markota, Stefan Endres, Sebastian Kobold
Molecular Therapy. Oncology|May 6, 2026
How CAR T cells can be shielded from prostaglandin E2 signaling to enhance their therapeutic activityJanina Dörr, David Andreu-Sanz, Sebastian Kobold
Mabs|March 21, 2019
Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cellsDiana Darowski, Sebastian Kobold, Christian Jost, et al.
Memo|November 15, 2021
CAR T cell therapy in solid tumors: a short reviewÖykü Umut, Adrian Gottschlich, Stefan Endres, et al.
Pageof 18